Endonovo Therapeutics Inc (ENDV)
0.0025
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Endonovo Therapeutics 1 Year Total Returns (Daily): -83.11% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -83.11% |
May 02, 2024 | -82.99% |
May 01, 2024 | -77.50% |
April 30, 2024 | -75.50% |
April 29, 2024 | -78.00% |
April 26, 2024 | -80.23% |
April 25, 2024 | -81.03% |
April 24, 2024 | -84.38% |
April 23, 2024 | -84.33% |
April 22, 2024 | -84.33% |
April 19, 2024 | -83.10% |
April 18, 2024 | -80.48% |
April 17, 2024 | -85.99% |
April 16, 2024 | -80.69% |
April 15, 2024 | -80.69% |
April 12, 2024 | -84.92% |
April 11, 2024 | -85.16% |
April 10, 2024 | -83.63% |
April 09, 2024 | -83.52% |
April 08, 2024 | -82.42% |
April 05, 2024 | -82.42% |
April 04, 2024 | -82.97% |
April 03, 2024 | -86.65% |
April 02, 2024 | -87.30% |
April 01, 2024 | -83.68% |
Date | Value |
---|---|
March 28, 2024 | -81.33% |
March 27, 2024 | -84.14% |
March 26, 2024 | -85.89% |
March 25, 2024 | -80.98% |
March 22, 2024 | -75.71% |
March 21, 2024 | -86.81% |
March 20, 2024 | -84.39% |
March 19, 2024 | -80.47% |
March 18, 2024 | -87.35% |
March 15, 2024 | -79.67% |
March 14, 2024 | -82.27% |
March 13, 2024 | -79.43% |
March 12, 2024 | -71.97% |
March 11, 2024 | -71.97% |
March 08, 2024 | -71.53% |
March 07, 2024 | -72.71% |
March 06, 2024 | -73.29% |
March 05, 2024 | -75.89% |
March 04, 2024 | -76.60% |
March 01, 2024 | -76.26% |
February 29, 2024 | -75.11% |
February 28, 2024 | -75.11% |
February 27, 2024 | -74.53% |
February 26, 2024 | -78.42% |
February 23, 2024 | -73.88% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.50%
Minimum
Jul 08 2020
103.2%
Maximum
Sep 25 2023
-57.35%
Average
-71.63%
Median
Aug 10 2021
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -90.79% |
Palatin Technologies Inc | -3.65% |
iBio Inc | -90.87% |
Theriva Biologics Inc | -37.06% |
Oragenics Inc | -59.32% |